Evolent Health, Inc.EVHNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +21.60% | +16.27% | -24.39% | -31.34% | -22.83% |
| Gross Profit Growth | -35.15% | -25.50% | -1.57% | -6.04% | +23.65% |
| EBITDA Growth | -35.30% | +0.00% | -252.81% | -64.86% | +21.56% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | -115.04% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | -1346.68% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.30% | +1.27% | +1.03% | +1.04% | -0.69% |
| Weighted Average Shares Diluted Growth | +2.30% | +1.27% | +1.03% | +1.04% | -0.69% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -69.15% | -129.35% | -7.01% | -241.64% | -15.31% |
| Free Cash Flow Growth | -76.96% | -138.86% | +0.00% | -373.24% | -44.67% |
| Receivables Growth | +3.47% | -7.18% | +0.64% | -4.01% | -5.23% |
| Inventory Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -6.29% | -5.07% | +0.37% | -0.55% | -1.93% |
| Book Value per Share Growth | -7.37% | -7.40% | -11.64% | -15.85% | -18.35% |
| Debt Growth | -2.81% | +10.68% | +35.30% | +34.21% | +70.39% |
| R&D Expense Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -30.56% | -42.28% | -0.88% | +8.71% | +12.59% |